Bedaquiline for multidrug-resistant TB in paediatric patients
Authors:
- R. MoodliarRMR. Moodliar
- on behalf of the TMC207-C211 study groupOGon behalf of the TMC207-C211 study group
Open Access
- 1 September 2021
- journal article
- research article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 25 (9) , 716-724
Abstract
BACKGROUND: TMC207-C211 (NCT02354014) is a Phase 2, open-label, multicentre, single-arm study to evaluate pharmacokinetics, safety/tolerability, antimycobacterial activity and dose selection of bedaquiline (BDQ) in children (birth to METHODS: Patients received 24 weeks’ BDQ with an anti-MDR-TB background regimen (BR), followed by 96 weeks of safety follow-up. Results of the primary analysis are presented based on data up to 24 weeks for Cohort 1 (≥12–CONCLUSION: In children and adolescents aged ≥5–<18 years with MDR-TB, including pre-extensively drug-resistant-TB (pre-XDR-TB) or XDR-TB, 24 weeks of BDQ provided a comparable pharmacokinetic and safety profile to adults.Keywords
This publication has 24 references indexed in Scilit:
- Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesThe Lancet, 2014
- Hearing loss in children treated for multidrug-resistant tuberculosisJournal of Infection, 2013
- Multidrug-resistant tuberculosis in children: evidence from global surveillanceEuropean Respiratory Journal, 2012
- Tuberculosis in ChildrenNew England Journal of Medicine, 2012
- Delamanid for Multidrug-Resistant Pulmonary TuberculosisNew England Journal of Medicine, 2012
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug ResistanceAntimicrobial Agents and Chemotherapy, 2012
- Childhood TB Surveillance: Bridging the Knowledge Gap to Inform PolicyJournal of Tropical Medicine, 2012
- The Diarylquinoline TMC207 for Multidrug-Resistant TuberculosisNew England Journal of Medicine, 2009
- Ensuring the Involvement of Children in the Evaluation of New Tuberculosis Treatment RegimensPLOS Medicine, 2008
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005